Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Multiple Sclerosis

Free Subscription 26.01.2026 1 Ann Neurol 3 BMC Neurol 1 Can J Neurol Sci 1 J Neurol Neurosurg Psychiatry 1 J Neurol Sci 2 Mult Scler 2 Neurology 1 PLoS Comput Biol 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. PISA M, Lockhart A, Angell T, Avery A, et al
   Topographical Variation of Iron-Rimmed Lesions in the Multiple Sclerosis Brain and Spinal Cord: A Neuropathological Study.
   Ann Neurol. 2026 Jan 18. doi: 10.1002/ana.78113.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. LEEUWENBERG KE, van der Molen LH, Boenink M, Richard E, et al
   The evolution of disease criteria in multiple sclerosis: underlying motives and broader implications.
   BMC Neurol. 2026 Jan 23. doi: 10.1186/s12883-026-04641.
   PubMed         Abstract available
   
   
3. KUCUKKAYA B, Kaydirak M
   The effect of multiple sclerosis on functional status and sexual quality of life in female patients with multiple sclerosis.
   BMC Neurol. 2026 Jan 22. doi: 10.1186/s12883-025-04584.
   PubMed        
   
   
4. YIN N, Li C, Zhao J, Cao Y, et al
   Development of a self-management journey map for people with multiple sclerosis: a qualitative study.
   BMC Neurol. 2026 Jan 19. doi: 10.1186/s12883-026-04631.
   PubMed        
   
   

   
   Can J Neurol Sci

5. ISLAM T, Berard JA, Walker LAS
   Perceived Cognitive Fatigability in Multiple Sclerosis: Input from People with Lived Experience on Unmet Needs.
   Can J Neurol Sci. 2026 Jan 20:1-29. doi: 10.1017/cjn.2026.10531.
   PubMed        
   
   

   
   J Neurol Neurosurg Psychiatry

6. KONEN FF, Axhausen F, Wolff S, Muhlenbrock P, et al
   Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.
   J Neurol Neurosurg Psychiatry. 2026 Jan 20:jnnp-2025-337944.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

7. AERTS S, Geys L, Severijns D, Alkhawajah M, et al
   Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews.
   J Neurol Sci. 2026;481:125756.
   PubMed         Abstract available
   
   

   
   Mult Scler

8. PRETZSCH R, El Mahdaoui S, Johnson P, Soares MD, et al
   Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials.
   Mult Scler. 2026 Jan 23:13524585251407973. doi: 10.1177/13524585251407973.
   PubMed         Abstract available
   
   
9. KUMARI S, Stephens S, Yoo PY, Arbour-Nicitopoulos KP, et al
   Built-environment correlates of physical activity in youth with multiple sclerosis.
   Mult Scler. 2026 Jan 20:13524585251407505. doi: 10.1177/13524585251407505.
   PubMed         Abstract available
   
   

   
   Neurology

10. LOCKHART A, Pisa M, Drakesmith H, DeLuca GC, et al
    Iron-Rim Lesions in the Optic Chiasm in Multiple Sclerosis: A Neuropathologic Case Series.
    Neurology. 2026;106:e214515.
    PubMed         Abstract available
    
    
11. CAGOL A, Granziera C
    Turning Our Gaze to the Anterior Visual Pathway: Iron Rim Lesions Come Into View in Multiple Sclerosis.
    Neurology. 2026;106:e214590.
    PubMed        
    
    

    
    PLoS Comput Biol

12. WEATHERLEY GR, Araujo RP, Dando SJ, Jenner AL, et al
    Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis.
    PLoS Comput Biol. 2026;22:e1013273.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

13. BOUTIERE C, Saunier R, Rico A, Perriguey M, et al
    Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.
    Rev Neurol (Paris). 2026 Jan 16:S0035-3787(26)00001.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.